Public Sector Pension Investment Board (PSP Investments)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
70,378
+2,264
+3% +$448K 0.04% 389
2025
Q4
$12.9M Sell
68,114
-8,330
-11% -$1.6M 0.04% 358
2025
Q3
$13.5M Buy
76,444
+10,644
+16% +$1.58M 0.05% 334
2025
Q2
$7.48M Buy
65,800
+5,922
+10% +$633K 0.03% 495
2025
Q1
$6.3M Buy
59,878
+12,783
+27% +$1.45M 0.03% 587
2024
Q4
$5.05M Buy
47,095
+8,348
+22% +$944K 0.02% 641
2024
Q3
$3.88M Buy
38,747
+1,500
+4% +$151K 0.02% 596
2024
Q2
$3.14M Buy
37,247
+3,649
+11% +$290K 0.02% 643
2024
Q1
$2.46M Sell
33,598
-420
-1% -$31K 0.02% 688
2023
Q4
$2.43M Buy
34,018
+13,854
+69% +$818K 0.02% 679
2023
Q3
$1.21M Sell
20,164
-8,963
-31% -$590K 0.01% 1029
2023
Q2
$2.1M Buy
29,127
+900
+3% +$67.5K 0.01% 894
2023
Q1
$2.08M Sell
28,227
-971
-3% -$69K 0.02% 895
2022
Q4
$1.95M Sell
29,198
-17,930
-38% -$1.17M 0.01% 932
2022
Q3
$2.53M Sell
47,128
-2,886
-6% -$170K 0.02% 692
2022
Q2
$2.78M Hold
50,014
0.02% 607
2022
Q1
$3.51M Sell
50,014
-4,552
-8% -$330K 0.02% 661
2021
Q4
$5.26M Buy
54,566
+545
+1% +$50.3K 0.03% 544
2021
Q3
$4.7M Buy
+54,021
New +$4.18M 0.03% 588
2021
Q2
Sell
-5,848
Closed -$556K 1474
2021
Q1
$556K Sell
5,848
-3,667
-39% -$347K ﹤0.01% 1371
2020
Q4
$590K Buy
+9,515
New +$542K ﹤0.01% 1290
2019
Q2
Sell
-22,282
Closed -$1.75M 1509
2019
Q1
$1.75M Buy
22,282
+5,523
+33% +$418K 0.02% 744
2018
Q4
$1.42M Sell
16,759
-15,154
-47% -$1.62M 0.01% 761
2018
Q3
$5.46M Sell
31,913
-1,569
-5% -$237K 0.04% 340
2018
Q2
$4.33M Buy
33,482
+11,542
+53% +$1.29M 0.03% 345
2018
Q1
$2.26M Sell
21,940
-6,733
-23% -$666K 0.02% 414
2017
Q4
$2.45M Buy
28,673
+7,534
+36% +$653K 0.02% 478
2017
Q3
$1.79M Buy
21,139
+5,354
+34% +$424K 0.01% 516
2017
Q2
$1.2M Sell
15,785
-6,412
-29% -$449K 0.01% 655
2017
Q1
$1.47M Buy
22,197
+641
+3% +$42.2K 0.01% 729
2016
Q4
$1.37M Hold
21,556
0.01% 743
2016
Q3
$1.37M Hold
21,556
0.01% 704
2016
Q2
$1.6M Buy
21,556
+962
+5% +$71.4K 0.02% 597
2016
Q1
$1.38M Hold
20,594
0.02% 607
2015
Q4
$1.39M Sell
20,594
-11,381
-36% -$703K 0.01% 667
2015
Q3
$1.71M Sell
31,975
-12,503
-28% -$759K 0.02% 702
2015
Q2
$2.8M Sell
44,478
-9,618
-18% -$525K 0.02% 661
2015
Q1
$2.6M Sell
54,096
-962
-2% -$36.9K 0.02% 756
2014
Q4
$1.83M Sell
55,058
-1,764
-3% -$57.4K 0.01% 904
2014
Q3
$1.67M Sell
56,822
-16,190
-22% -$537K 0.01% 923
2014
Q2
$2.84M Buy
73,012
+6,327
+9% +$257K 0.02% 766
2014
Q1
$2.8M Sell
66,685
-12,984
-16% -$541K 0.02% 719
2013
Q4
$2.61M Buy
+79,669
New +$2.6M 0.02% 824

Other funds holding LGND

Public Sector Pension Investment Board (PSP Investments)'s LGND Position: Q1 2026 in Review

Public Sector Pension Investment Board (PSP Investments) increased its Ligand Pharmaceuticals (LGND) stake by 3.3% in Q1 2026, buying an estimated $448K and bringing the position to 70,378 shares worth $14.1M. The position accounts for 0.04% of the portfolio, ranked #389.

Public Sector Pension Investment Board (PSP Investments) first reported a position in LGND in Q4 2013 and has held it in 43 quarters since. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 70,378 shares of Ligand Pharmaceuticals worth $14.1M as of Q1 2026.
  • Public Sector Pension Investment Board (PSP Investments) bought 2,264 Ligand Pharmaceuticals shares in Q1 2026, an estimated $448K.
  • Ligand Pharmaceuticals made up 0.04% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q1 2026, its #389 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 43 quarters since.
  • 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2026, filed 13 May 2026.